论文信息 - The argument for rapid influenza polymerase chain reaction (PCR) during the COVID-19 pandemic: Quicker turnaround times correlated with decreased antimicrobial use, reduced admission rates, and shorter length of stay

The argument for rapid influenza polymerase chain reaction (PCR) during the COVID-19 pandemic: Quicker turnaround times correlated with decreased antimicrobial use, reduced admission rates, and shorter length of stay

Abstract The innovation of rapid influenza polymerase chain reaction (XT-PCR) has allowed quick, highly sensitive test results. Consequently, physicians can differentiate influenza from other respiratory illnesses and rapidly initiate treatment. We examined the effect of implementing XT-PCR on antimicrobial use, admission rates, and length of stay at a tertiary healthcare system.

T. Chopra | Alpana Garg | Avnish Sandhu | Jordan Polistico | Jennifer J. LeRose

[1] M. C. Jaklevic. Flu Vaccination Urged During COVID-19 Pandemic. , 2020, JAMA.

[2] Xian-gao Jiang,et al. Differential diagnosis for suspected cases of coronavirus disease 2019: a retrospective study , 2020, BMC Infectious Diseases.

[3] Lanjuan Li,et al. Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID‐19) , 2020, Journal of internal medicine.

[4] A. Dugas,et al. Evaluation of the Xpert Flu Rapid PCR Assay in High-Risk Emergency Department Patients , 2014, Journal of Clinical Microbiology.

[5] J. Steurer,et al. A decision aid to rule out pneumonia and reduce unnecessary prescriptions of antibiotics in primary care patients with cough and fever , 2011, BMC medicine.

[6] M. Shaw,et al. Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) Virus - United States, 2009. , 2009, MMWR. Morbidity and mortality weekly report.

[7] F Y Aoki,et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. , 2003, The Journal of antimicrobial chemotherapy.